Risk of Renal Dysfunction Following Heart Transplantation in Patients Bridged with a Left Ventricular Assist Device.
Journal
ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109
Informations de publication
Date de publication:
01 05 2022
01 05 2022
Historique:
pubmed:
23
8
2021
medline:
6
5
2022
entrez:
22
8
2021
Statut:
ppublish
Résumé
Acute renal failure (ARF) and chronic kidney disease (CKD) are associated with short- and long-term morbidity and mortality following heart transplantation (HT). We investigated the incidence and risk factors for developing ARF requiring hemodialysis (HD) and CKD following HT specifically in patients with a left ventricular assist device (LVAD). We examined the International Society for Heart and Lung Transplantation (ISHLT) Thoracic Transplant Registry for heart transplant patients between January 2000 and June 2015. We compared patients bridged with durable continuous-flow LVAD to those without LVAD support. Primary outcomes were ARF requiring HD before discharge following HT and CKD (defined as creatinine >2.5 mg/dl, permanent dialysis, or renal transplant) within 3 years. There were 18,738 patients, with 4,535 (24%) bridged with LVAD support. Left ventricular assist device patients had higher incidence of ARF requiring HD and CKD at 1 year, but no significant difference in CKD at 3 years compared to non-LVAD patients. Among LVAD patients, body mass index (BMI) (odds ratio [OR] = 1.79, p < 0.001), baseline estimated glomerular filtration rate (eGFR) (OR = 0.43, p < 0.001), and ischemic time (OR = 1.28, p = 0.014) were significantly associated with ARF requiring HD. Similarly, BMI (hazard ratio [HR] = 1.49, p < 0.001), baseline eGFR (HR = 0.41, p < 0.001), pre-HT diabetes mellitus (DM) (HR = 1.37, p = 0.011), and post-HT dialysis before discharge (HR = 3.93, p < 0.001) were significantly associated with CKD. Left ventricular assist device patients have a higher incidence of ARF requiring HD and CKD at 1 year after HT compared with non-LVAD patients, but incidence of CKD is similar by 3 years. Baseline renal function, BMI, ischemic time, and DM can help identify LVAD patients at risk of ARF requiring HD or CKD following HT.
Identifiants
pubmed: 34419984
doi: 10.1097/MAT.0000000000001558
pii: 00002480-202205000-00005
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
646-653Informations de copyright
Copyright © ASAIO 2021.
Références
Pinney SP, Anyanwu AC, Lala A, Teuteberg JJ, Uriel N, Mehra MR: Left ventricular assist devices for lifelong support. J Am Coll Cardiol 69: 2845–2861, 2017.
Benjamin EJ, Blaha MJ, Chiuve SE, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation 135: e146–e603, 2017.
Yancy CW, Jessup M, Bozkurt B, et al.: 2013 ACCF/AHA guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128: 1810–1852, 2013.
Stehlik J, Edwards LB, Kucheryavaya AY, et al.: The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult heart transplant report--2010. J Hear Lung Transpl 29: 1089–1103, 2010.
Khush KK, Cherikh WS, Chambers DC, et al.: The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report — 2019; focus theme: Donor and recipient size match. J Hear Lung Transplant 38: 1056–1066, 2019.
Wyatt CM, Arons RR: The burden of acute renal failure in nonrenal solid organ transplantation. Transplantation 78: 1351–1355, 2004.
Ojo AO, Held PJ, Port FK, et al.: Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349: 931–940, 2003.
Gude E, Andreassen AK, Arora S, et al.: Acute renal failure early after heart transplantation: Risk factors and clinical consequences. Clin Transpl 24: E207–E213, 2010.
Clajus C, Hanke N, Gottlieb J, et al.: Renal comorbidity after solid organ and stem cell transplantation. Am J Transpl 12: 1691–1699, 2012.
De Santo LS, Romano G, Amarelli C, et al.: Implications of acute kidney injury after heart transplantation: What a surgeon should know. Eur J Cardiothorac Surg 40: 1355–1361; discussion 1361, 2011.
Ivey-Miranda JB, Flores-Umanzor E, Farrero-Torres M, Santiago E, Cepas-Guillen PL, Perez-Villa F: Predictors of renal replacement therapy after heart transplantation and its impact on long-term survival. Clin Transpl 32: e13401, 2018.
Takeda K, Takayama H, Kalesan B, et al.: Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support. J Hear Lung Transpl 34: 89–99, 2015.
Rose EA, Gelijns AC, Moskowitz AJ, et al.; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group: Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345: 1435–1443, 2001.
Magruder JT, Grimm JC, Crawford TC, et al.: Survival after orthotopic heart transplantation in patients undergoing bridge to transplantation with the HeartWare HVAD versus the heartmate II. Ann Thorac Surg 103: 1505–1511, 2017.
Estep JD, Starling RC, Horstmanshof DA, et al.; ROADMAP Study Investigators: Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: Results from the ROADMAP study. J Am Coll Cardiol 66: 1747–1761, 2015.
Brouwers C, de Jonge N, Caliskan K, et al.: Predictors of changes in health status between and within patients 12 months post left ventricular assist device implantation. Eur J Hear Fail 16: 566–573, 2014.
Hasin T, Topilsky Y, Schirger JA, et al.: Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol 59: 26–36, 2012.
Patel AM, Adeseun GA, Ahmed I, Mitter N, Rame JE, Rudnick MR: Renal failure in patients with left ventricular assist devices. Clin J Am Soc Nephrol 8: 484–496, 2013.
Rossi AP, Vella JP: Acute kidney disease after liver and heart transplantation. Transplantation 100: 506–514, 2016.
Zalawadiya SK, Wigger M, DiSalvo T, Haglund N, Maltais S, Lindenfeld J: Mechanical circulatory support and simultaneous heart-kidney transplantation: An outcome analysis. J Hear Lung Transpl 35: 203–212, 2016.
Kilic A, Grimm JC, Shah AS, Conte JV, Whitman GJ, Sciortino CM: An easily calculable and highly predictive risk index for postoperative renal failure after heart transplantation. J Thorac Cardiovasc Surg 148: 1099–1104; discussion 1104, 2014.
ISHLT: The International Society for Heart & Lung Transplantation - International Thoracic Organ Transplant (TTX) Registry Data Forms: Available at: https://ishlt.org/research-data/registries/ttx-registry/ttx-data-forms . Accessed February 10, 2021.
Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94: 496–509, 1999.
Harrell FE Jr, Dupont C: Hmisc: Harrell Miscellaneous. R package version 4.2-0. 2019. Available at: https://cran.r-project.org/package=Hmisc . Accessed July 1, 2019.
Lund LH, Khush KK, Cherikh WS, et al.: The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. J Hear Lung Transpl 36: 1037–1046, 2017.
Russell SD, Rogers JG, Milano CA, et al.; HeartMate II Clinical Investigators: Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120: 2352–2357, 2009.
Gaffey AC, Phillips EC, Howard J, et al.: Prior sternotomy and ventricular assist device implantation do not adversely impact survival or allograft function after heart transplantation. Ann Thorac Surg 100: 542–549, 2015.
Stone ML, LaPar DJ, Benrashid E, et al.: Ventricular assist devices and increased blood product utilization for cardiac transplantation. J Card Surg 30: 194–200, 2015.
Boyle JM, Moualla S, Arrigain S, et al.: Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis 48: 787–796, 2006.
Axtell AL, Fiedler AG, Melnitchouk S, et al.: Correlation of cardiopulmonary bypass duration with acute renal failure after cardiac surgery. J Thorac Cardiovasc Surg 159: 170–178.e2, 2020.
Kindzelski BA, Corcoran P, Siegenthaler MP, Horvath KA: Postoperative acute kidney injury following intraoperative blood product transfusions during cardiac surgery. Perfusion 33: 62–70, 2018.
Singh M, Shullo M, Kormos RL, et al.: Impact of renal function before mechanical circulatory support on posttransplant renal outcomes. Ann Thorac Surg 91: 1348–1354, 2011.
Zou Z, Zhuang Y, Liu L, et al.: Role of body mass index in acute kidney injury patients after cardiac surgery. Cardiorenal Med 8: 9–17, 2017.
Billings FT IV, Pretorius M, Schildcrout JS, et al.: Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol 23: 1221–1228, 2012.
Serra A, Romero R, Lopez D, et al.: Renal injury in the extremely obese patients with normal renal function. Kidney Int 73: 947–955, 2008.
Rogers JG, Pagani FD, Tatooles AJ, et al.: Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med 376: 451–460, 2017.
Mehra MR, Goldstein DJ, Uriel N, et al.: Two-Year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med 378: 1386–1395, 2018.
Mehra MR, Naka Y, Uriel N, et al.; MOMENTUM 3 Investigators: A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med 376: 440–450, 2017.
Shah P, Badoe N, Phillips S, et al.: Unrecognized left heart failure in LVAD recipients: The role of routine invasive hemodynamic testing. ASAIO J 64: 183–190, 2018.
Imamura T, Jeevanandam V, Kim G, et al.: Optimal hemodynamics during left ventricular assist device support are associated with reduced readmission rates. Circ Heart Fail 12: e005094, 2019.